州级无家可归和药物过量死亡率:来自美国小组数据的证据
1Arizona State University, Phoenix, AZ, USA.
Drug and alcohol dependence
|August 3, 2023
概括
国家层面的无家可归与美国过量吸毒死亡人数的增加有关. 减少无家可归是解决过量危机的关键,尽管芬太尼的可用性可能会减轻这种影响.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 社会学 社会学 社会学
背景情况:
- 无家可归是已知的药物过量个体水平风险.
- 关于美国州级无家可归和过量死亡率之间的关联,人们的理解有限.
研究的目的:
- 调查美国各州州级无家可归率与过量药物使用死亡率之间的关系.
- 检查药物供应,特别是芬太尼的可用性对这种关联的潜在缓解影响.
主要方法:
- 利用来自联邦机构 (HUD,CDC,BLS) 和NFLIS的2007-2020年面板数据.
- 采用双向固定效应模型来分析无家可归患病率和过量服用死亡率之间的关联,控制人口统计和失业率.
- 纳入药物扣押数据以评估芬太尼可用性的影响.
主要成果:
- 在州无家可归率和药物过量死亡率之间发现了显著的积极关联.
- 在芬太尼可用性较高的州,这种关联减弱,表明具有缓和作用.
- 在调整了各种混因素和全国趋势后,调查结果仍然强.
结论:
- 国家层面的无家可归是药物过量死亡率的重要预测因素.
- 旨在预防和减少无家可归的政策是打击美国过量使用危机的综合战略的重要组成部分.
- 无家可归对过量死亡率的影响可能会受到特定药物的患病率的影响,例如芬太尼.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.5K
10:13Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
2.3K
相关概念视频
Substance Use Disorders Affecting Sleep
196
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
196
Drug Abuse and Addiction: Pharmacological Phenomena
521
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
521
Drug Dependence
1.1K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.1K
Healthcare Agencies II
724
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
724
Analysis of Population Pharmacokinetic Data
296
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
296
Drug Control Governance: Regulatory Bodies and Their Impact
184
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
184
